Srikala Sridhar

Division of Medical Oncology

University Health Network – Princess Margaret Hospital

Sridhar Srikala

Sign the Guestbook

All messages are held for moderation.


Dr. Sridhar’s focus is on novel approaches to the management of genitourinary (GU) cancers. She has designed and led a number of seminal clinical trials, serving as study chair of 4 investigator-initiated clinical trials and sitting on the steering committee of 4 international Phase 3 clinical trials. Dr. Sridhar has also contributed to improvements in the design and conduct of GU oncology trials. For example, she has conducted research to better understand reasons for exclusion of patients from clinical trials in advanced GU cancer and led an international effort to standardize eligibility and endpoint criteria in clinical trials in prostate cancer. She has served on multiple committees at the provincial and national level, as well as in the US, supporting development of standards of care and clinical practice guidelines. She is one of a group of 8 GU medical oncologists from around the world known as Uromigos who have a twitter handle, tweet and do regular podcasts on key topics.